Author:
Wolska-Washer Anna,Robak Tadeusz
Funder
Uniwersytet Medyczny w Lodzi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference79 articles.
1. Dan N, Setua S, Kashyap VK, Khan S, Jaggi M, Yallapu MM, Chauhan SC. Antibody-drug conjugates for cancer therapy: chemistry to clinical implications. Pharmaceuticals (Basel). 2018;11(2):E32.
2. Gromek SM, Balunas MJ. Natural products as exquisitely potent cytotoxic payloads for antibody-drug conjugates. Curr Top Med Chem. 2015;14(24):2822–34.
3. Jain N, Smith SW, Ghone S, Tomczuk B. Current ADC linker chemistry. Pharm Res. 2015;32:3526–40.
4. Cianfriglia M. The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicin. Ann Ist Super Sanita. 2013;49(2):150–68.
5. European Medicines Agency. Mylotarg: summary of product characteristics.
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004204/WC500248702
. Accessed 11 Dec 2018.
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献